Infusion of Human Umbilical Cord Blood Cells Ameliorates Hind Limb Dysfunction in Experimental Spinal Cord Injury through Anti-inflammatory, Vasculogenic and Neurotrophic Mechanisms

Pediatrics and Neonatology

Volumn 49, Issue 3, 2008, Pages 77-83

  Chen, Chun Ta ^a   Foo, Ning Hui ^a   Liu, Won Shiung ^a   Chen, Sheng Hsien ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

glial cell line derived neurotrophic factor; human umbilical cord blood cells; interleukin 10; spinal cord injury; vascular endothelial growth factor

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; HINDLIMB; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LAMINECTOMY; LIMB DISEASE; MALE; NEUROTROPISM; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN BLOOD LEVEL; RAT; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SYSTEMIC THERAPY; THERAPY EFFECT;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HINDLIMB; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55549135371     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1875-9572(08)60017-0     Document Type: Article

References (32)

1. Cohen S.B., Wang X.N., and Dickinson A. Can cord blood cells support the cytokine storm in GvHD?. Cytokine Growth Factor Rev 11 (2000) 185-197
2. Lu L., Shen R.N., and Broxmeyer H.E. Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Crit Rev Oncol Hematol 22 (1996) 61-78
3. Lewis I.D. Clinical and experimental uses of umbilical cord blood. Intern Med J 32 (2002) 601-609
4. Zhao Z.M., Li H.J., Liu H.Y., et al. Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant 13 (2004) 113-122
5. Nishio Y., Koda M., Kamada T., et al. The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hind-limb function in adult rats. J Neurosurg Spine 5 (2006) 424-433
6. Saporta S., Kim J.J., Willing A.E., Fu E.S., Davis C.D., and Sanberg P.R. Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J Hematother Stem Cell Res 12 (2003) 271-278
7. Donnelly D.J., and Popovich P.G. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209 (2008) 378-388
8. Zola H., Fusco M., Macardle P.J., Flego L., and Roberton D.M. Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res 38 (1995) 397-403
9. Rainsford E., and Reen D.J. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 116 (2002) 702-709
10. Rivlin A.S., and Tator C.H. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10 (1978) 38-43
11. Hallam T.M., Floyd C.L., Folkerts M.M., et al. Comparison of behavioral deficits and acute neuronal degeneration in rat lateral fluid percussion and weight-drop brain injury models. J Neurotrauma 21 (2004) 521-529
12. Vendrame M., Cassady J., Newcomb J., et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35 (2004) 2390-2395
13. Nieda M., Nicol A., Denning-Kendall P., Sweetenham J., Bradley B., and Hows J. Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 98 (1997) 775-777
14. Sirchia G., and Rebulla P. Placental/umbilical cord blood transplantation. Haematologica 84 (1999) 738-747
15. Chen J., Sanberg P.R., Li Y., et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
16. Willing A.E., Lixian J., Milliken M., et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res 73 (2003) 296-307
17. Lu D., Sanberg P.R., Mahmood A., et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant 11 (2002) 275-281
18. Davies A.L., Hayes K.C., and Dekaban G.A. Clinical correlates of elevated serum concentrations of cytokines and autoanti-bodies in patients with spinal cord injury. Arch Phys Med Rehabil 88 (2007) 1384-1393
19. Chen S.H., Chang F.M., Chang H.K., Chen W.C., Huang K.F., and Lin M.T. Human umbilical cord blood-derived CD34+ cells cause attenuation of multiorgan dysfunction during experimental heatstroke. Shock 27 (2007) 663-671
20. Oberholzer A., Oberholzer C., and Moldawer L.L. Cytokine signaling: regulation of the immune response in normal and critically ill states. Crit Care Med 28 4 Suppl (2002) N3-12
21. Yla-Herttuala S., and Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 9 (2003) 694-701
22. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., and Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99 (2002) 11946-11950
23. Taguchi A., Soma T., Tanaka H., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114 (2004) 330-338
24. Borlongan C.V., Hadman M., Sanberg C.D., and Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35 (2004) 2385-2389
25. Abe K., and Hayashi T. Expression of the glial cell line-derived neurotrophic factor gene in rat brain after transient MCA occlusion. Brain Res 776 (1997) 230-234
26. Kokaia Z., Zhao Q., Kokaia M., et al. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp Neurol 136 (1995) 73-88
27. Beck K.D., Valverde J., Alexi T., et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373 (1995) 339-341
28. Oppenheim R.W., Houenou L.J., Johnson J.E., et al. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 373 (1995) 344-346
29. Zhang W.R., Hayashi T., Iwai M., et al. Time-dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat. Brain Res 903 (2001) 253-256
30. Zhang W.R., Sato K., Iwai M., Nagano I., Manabe Y., and Abe K. Therapeutic time window of adenovirus-mediated GDNF gene transfer after transient middle cerebral artery occlusion in rat. Brain Res 947 (2002) 140-145
31. Kurozumi K., Nakamura K., Tamiya T., et al. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model. Mol Ther 11 (2005) 96-104
32. Kao C.H., Chen S.H., Chio C.C., Chang C.K., and Lin M.T. Exogenous administration of glial cell line-derived neurotrophic factor improves recovery after spinal cord injury. Resuscitation 77 (2008) 395-400